| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Nov 14, 2025 | Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | Sell | 3.8 | -196,538 | -67.20% | ✓ | $7.4M |
| Sep 21, 2023 | Sep 25, 2023 | Dianthus Therapeutics, Inc. /DE/ | Chief Medical Officer | Buy | 95.0 | +4,000 | 100.00% | ✗ | $52.8K |